Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pharma4ever Engineering ApS
APS
Active
Advertising protection
CVR 41699477
Fredensborgvej 26C, 3080
Tikøb
Engineering activities and related technical consultancy
·
NACE 7112
Est. 2020 · 5 years old
8 employees
www.Pharma4ever.com
Monitor
Share
Denmark
/
Companies
/
Engineering activities and related technical consultancy
/
Pharma4ever Engineering ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
19M
14M
9M
5M
0M
1M
2021
4M
+300%
2022
15M
+275%
2023
14M
-7%
2024
13M
-7%
2025
EBITDA
DKK millions
5M
4M
3M
1M
0M
0M
2021
1M
+100%
2022
4M
+300%
2023
2M
-50%
2024
3M
+50%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
1.056
3.835
14.767
14.220
12.586
Staff expenses
-932
-2.929
-10.876
-12.703
-9.540
EBITDA
124
906
3.891
1.517
3.046
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
124
906
3.891
1.517
3.046
Net financials
-21
-45
-15
-181
-65
Profit before tax
103
861
3.876
1.336
2.982
Tax
25
191
856
298
656
Net profit
78
671
3.020
1.038
2.325
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
287
3.237
8.261
7.473
5.582
Equity
118
788
3.158
1.078
2.365
Long-term debt
0
0
0
0
0
Short-term debt
169
2.448
5.103
6.396
3.217
Total debt
169
2.448
5.103
6.396
3.217
Financial ratios
5-year trend
EBITDA margin (of gross profit)
24.2%
This company
2021
2025
Equity ratio
42.4%
This company
38.2%
Market median
11% above market
2021
2025
Return on equity
98.3%
This company
18.4%
Market median
434% above market
2021
2025
Net profit margin (of gross profit)
18.5%
This company
2021
2025
Asset turnover (of gross profit)
2.25×
This company
2021
2025
Debt / equity
1.36×
This company
0.62×
Market median
119% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-09-22 – 2021-12-31
View
PDF
More on Pharma4ever Engineering ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
